1322724-40-2Relevant academic research and scientific papers
Design, synthesis, biological evaluation, and computational studies of novel thiazolo-pyrazole hybrids as promising selective COX-2 inhibitors: Implementation of apoptotic genes expression for ulcerogenic liability assessment
Marzouk, Adel A.,Taher, Ehab S.,Shaykoon, Montaser Sh. A.,Lan, Ping,Abd-Allah, Walaa Hamada,Aboregela, Adel M.,El-Behairy, Mohammed Farrag
, (2021/04/19)
A novel series of thiazolo-pyrazole hybrids has been prepared and assessed for their in vitro COX-1/COX-2 inhibitory activity. Compound 6c exhibited the most selective COX-2 inhibition profile (SI of 264) not far of Celecoxib (2 9 4). In-vivo anti-inflamm
Synthesis and anti-inflammatory activity of some pyrazole derivatives
El-Moghazy, Samir M.,Barsoum, Flora F.,Abdel-Rahman, Hamdy M.,Marzouk, Adel A.
, p. 1722 - 1733,12 (2020/07/30)
A novel series of pyrazoles containing benzenesulfonamides, 1,3,4-oxadiazole-2-thiones, 4-substituted-1,2,4-triazole-3-thiones, and 2-substituted-1,3,4-thiadiazoles has been synthesized. Anti-inflammatory activity of some synthesized compounds was evaluated in vivo utilizing a standard acute carrageenan-induced paw edema method. The most active anti-inflammatory agents 3, 8f, and 10f were evaluated for ulcerogenic liability in rats compared to indomethacin and celecoxib as reference standards. Molecular modeling studies were initiated herein to validate the attained pharmacological data and provide understandable evidence for the observed anti-inflammatory behavior.
